GOSSAMER BIO, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $222.2M | $343.7M | $183.4M |
| FY2022 | $260.4M | $272.5M | $112.0M |
| FY2023 | $249.1M | $311.9M | $32.1M |
| FY2024 | $285.8M | $315.3M | $46.1M |
| FY2025 | $295.0M | $172.2M | $37.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $222.2M | $343.7M | $183.4M |
| FY2022 | $260.4M | $272.5M | $112.0M |
| FY2023 | $249.1M | $311.9M | $32.1M |
| FY2024 | $285.8M | $315.3M | $46.1M |
| FY2025 | $295.0M | $172.2M | $37.7M |